Strong Well Results and Successful Acquisition Integration Drive Increased Full Year Production Guidance Highlights: Generated net earnings of $406 million, cash from operating activities of $906 million, Non-GAAP Cash Flow of $1,112 million and Non-GAAP Free Cash Flow of $278 million after capital expenditures of $834 million Third quarter production was at or above the… Continue reading Ovintiv Reports Third Quarter 2023 Financial and Operating Results
Tag: Financial Results
BOARDWALK REIT REPORTS STRONG THIRD QUARTER RESULTS WITH CONTINUED OPERATING MARGIN IMPROVEMENT
CALGARY, AB, Nov. 7, 2023 /PRNewswire/ – Boardwalk Real Estate Investment Trust (TSX: BEI.UN) SUMMARY HIGHLIGHTS FOR THE THREE AND NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2023 STRONG FINANCIAL PERFORMANCE FOR THE 3 MONTH PERIOD ENDED SEPTEMBER 30, 2023 Profit of $39.4 million Funds From Operations (“FFO”) of $0.96 per Unit(1)(2); an increase of 12.9% from… Continue reading BOARDWALK REIT REPORTS STRONG THIRD QUARTER RESULTS WITH CONTINUED OPERATING MARGIN IMPROVEMENT
Vitiligo Market Growth to Undergo Significant Changes by 2032, Predicts DelveInsight | Key Companies in the Market – Clinuvel Pharmaceuticals Limited, Pfizer, Incyte Corporation, Amgen
The available therapeutics treatment options in the vitiligo market landscape aim to reduce complications arising. The dynamics of the vitiligo market are anticipated to change in the coming years owing to the improvement in the rise in number of healthcare spending across the world. LAS VEGAS, Nov. 7, 2023 /PRNewswire/ — DelveInsight’s Vitiligo Market Insights report… Continue reading Vitiligo Market Growth to Undergo Significant Changes by 2032, Predicts DelveInsight | Key Companies in the Market – Clinuvel Pharmaceuticals Limited, Pfizer, Incyte Corporation, Amgen
RIV Capital Completes Expansion of New York Cultivation and Production Operations
Recently completed expansion of Chestertown facility triples current cannabis production capacity Enhanced research and development capabilities to drive product innovation Strongly positioned to become a leading supplier to the New York adult-use cannabis market TORONTO, Nov. 7, 2023 /PRNewswire/ – RIV Capital Inc. (CSE: RIV) (OTC: CNPOF) (“RIV” or the “Company”), a cannabis acquisition and… Continue reading RIV Capital Completes Expansion of New York Cultivation and Production Operations
Westport Fuel Systems Reports Third Quarter 2023 Financial Results
VANCOUVER, BC, November 7, 2023 /PRNewswire/ – Westport Fuel Systems Inc. (“Westport“) (TSX: WPRT) (Nasdaq: WPRT), a leading supplier of advanced alternative fuel systems and components for the global transportation industry, reported financial results for the third quarter ended September 30, 2023, and provided an update on operations. All figures are in U.S. dollars unless otherwise… Continue reading Westport Fuel Systems Reports Third Quarter 2023 Financial Results
Westport Fuel Systems Reports Third Quarter 2023 Financial Results
VANCOUVER, BC, November 7, 2023 /PRNewswire/ — Westport Fuel Systems Inc. (“Westport“) (TSX: WPRT) (Nasdaq: WPRT), a leading supplier of advanced alternative fuel systems and components for the global transportation industry, reported financial results for the third quarter ended September 30, 2023, and provided an update on operations. All figures are in U.S. dollars unless otherwise… Continue reading Westport Fuel Systems Reports Third Quarter 2023 Financial Results
Darling Ingredients Inc. Reports Third Quarter 2023 Results
Third Quarter 2023 Net income of $125.0 million, or $0.77 per GAAP diluted share Net sales of $1.6 billion Combined adjusted EBITDA of $334.3 million Global ingredients business EBITDA of $247.8 million Received $62.2 million in cash dividends from Diamond Green Diesel IRVING, Texas, Nov. 7, 2023 /PRNewswire/ — Darling Ingredients Inc. (NYSE: DAR) today… Continue reading Darling Ingredients Inc. Reports Third Quarter 2023 Results
Comerica Declares Common and Preferred Stock Dividends
DALLAS, Nov. 7, 2023 /PRNewswire/ — The Board of Directors of Comerica Incorporated (NYSE: CMA) declared a quarterly cash dividend for common stock of 71 cents ($0.71) per share. The dividend is payable Jan. 1, 2024, to common stock shareholders of record at the close of business on Dec. 15, 2023. The Board also declared… Continue reading Comerica Declares Common and Preferred Stock Dividends
Nektar Therapeutics Reports Third Quarter 2023 Financial Results
SAN FRANCISCO, Nov. 7, 2023 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the third quarter ended September 30, 2023. Cash and investments in marketable securities at September 30, 2023, were $372.7 million as compared to $505.0 million at December 31, 2022. Nektar’s cash and marketable securities are expected to support strategic… Continue reading Nektar Therapeutics Reports Third Quarter 2023 Financial Results
AGS REPORTS THIRD QUARTER 2023 RESULTS
Third Quarter 2023 Highlights: Total Revenue Increased 14% Y/Y to $89.4 Million; Strong Growth Achieved Across All Three Segments Domestic EGM Recurring Revenue Grew 6% Y/Y; Far Outpacing Market-Wide GGR Trends Global EGM Sales Increased More Than 30% Y/Y to 1,345 Units Interactive Revenue Reached a Record $3.1 Million; Y/Y Growth Surpassed 20% Generated a Modest Net Loss… Continue reading AGS REPORTS THIRD QUARTER 2023 RESULTS